Possible extrapyramidal system degradation in Parkinson's disease

被引:10
作者
Drobny, M [1 ]
Kurca, E [1 ]
机构
[1] Comenius Univ, Jessenius Fac Med, Neurol Clin, Martin 03601, Slovakia
关键词
apoptosis; programmed cell death; oxidative stress; excitotoxicity; dopamine agonists;
D O I
10.1016/S0361-9230(00)00367-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Extrapyramidal system, a rich network of nerve and glial cells consists of subcortical and cortical grey matter. The system serves as an integrator of unaware, automatic, repeated, spontaneous, complicated and purposeful motor samples. Muscle tone regulation and its distribution is another decisive extrapyramidal function, This review article concerns to some degradation mechanisms in extrapyramidal system, as either the programmed cell death or apoptosis, The physiologic extracellular decreasing signals creating apoptosis (nerve growth factor-fall) are either genetically expressed or there are neuropathophysiologic processes that may activate pathways leading to apoptosis, namely oxidative stress, glutamate toxicity and calcium homeostasis disruption. The level of dopamine transporter expression (mRNA, methyl-phenyl-pyridinium) might determine the vulnerability of the nigral neurons to the Parkinsonian insult, The most common clinical picture of extrapyramidal disorder-Parkinson's disease- consists of an active dopamine cell death-apoptosis, which is partially programmed like as programmed cell death and partially accidentally installed chain of events, Without morphological criteria, biochemical indicators such as laddered DNA fragmentation pattern and/or the requirement for macromolecular synthesis merely suggest but do not provide unequivocal evidence for apoptosis. There are either genetic or acquired conditions creating unbalance of Bax/Bcl-2 families-proapoptotic and prooncogenic factors, respectively, The first Bax gene cooperates with other genes coding the new transmembrane proteins into the mitochondrial megapores determinating transition by means of death receptors. Bcl-2 codes prooncogenic mitoses and tissue proliferation. The neuroprotective hypothesis of the dopamine agonist action is a very attractive working hypothesis and some of its tenets are derived from the oxidative stress hypothesis for neurodegeneration, but this hypothesis is still controversial. (C) 2000 Elsevier Science Inc.
引用
收藏
页码:425 / 430
页数:6
相关论文
共 44 条
[1]   GLUTAMATE-INDUCED NEURONAL DEATH - A SUCCESSION OF NECROSIS OR APOPTOSIS DEPENDING ON MITOCHONDRIAL-FUNCTION [J].
ANKARCRONA, M ;
DYPBUKT, JM ;
BONFOCO, E ;
ZHIVOTOVSKY, B ;
ORRENIUS, S ;
LIPTON, SA ;
NICOTERA, P .
NEURON, 1995, 15 (04) :961-973
[2]   BCL-2 PREVENTS KILLING OF NEURONAL CELLS BY GLUTAMATE BUT NOT BY AMYLOID-BETA PROTEIN [J].
BEHL, C ;
HOVEY, L ;
KRAJEWSKI, S ;
SCHUBERT, D ;
REED, JC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 197 (02) :949-956
[3]  
CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171
[4]   CHEMISTRY AND BIOCHEMISTRY OF 4-HYDROXYNONENAL, MALONALDEHYDE AND RELATED ALDEHYDES [J].
ESTERBAUER, H ;
SCHAUR, RJ ;
ZOLLNER, H .
FREE RADICAL BIOLOGY AND MEDICINE, 1991, 11 (01) :81-128
[5]   IDENTIFICATION OF PROGRAMMED CELL-DEATH INSITU VIA SPECIFIC LABELING OF NUCLEAR-DNA FRAGMENTATION [J].
GAVRIELI, Y ;
SHERMAN, Y ;
BENSASSON, SA .
JOURNAL OF CELL BIOLOGY, 1992, 119 (03) :493-501
[6]   A COMPARISON OF CLINICAL AND PATHOLOGICAL FEATURES OF YOUNG-ONSET AND OLD-ONSET PARKINSONS-DISEASE [J].
GIBB, WRG ;
LEES, AJ .
NEUROLOGY, 1988, 38 (09) :1402-1406
[7]   SUPEROXIDE-DISMUTASE DELAYS NEURONAL APOPTOSIS - A ROLE FOR REACTIVE OXYGEN SPECIES IN PROGRAMMED NEURONAL DEATH [J].
GREENLUND, LJS ;
DECKWERTH, TL ;
JOHNSON, EM .
NEURON, 1995, 14 (02) :303-315
[8]   A C-JUN DOMINANT-NEGATIVE MUTANT PROTECTS SYMPATHETIC NEURONS AGAINST PROGRAMMED CELL-DEATH [J].
HAM, J ;
BABIJ, C ;
WHITFIELD, J ;
PFARR, CM ;
LALLEMAND, D ;
YANIV, M ;
RUBIN, LL .
NEURON, 1995, 14 (05) :927-939
[9]   Inhibition of cellular growth and induction of apoptosis in pituitary adenoma cell lines by the protein kinase C inhibitor hypericin: Potential therapeutic application [J].
Hamilton, HB ;
Hinton, DR ;
Law, RE ;
Gopalakrishna, R ;
Su, YZ ;
Chen, ZH ;
Weiss, MH ;
Couldwell, WT .
JOURNAL OF NEUROSURGERY, 1996, 85 (02) :329-334
[10]  
HART J, 1994, MICROCONTAMINATION, V12, P63